These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8239630)

  • 1. Influence of circadian-stage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats.
    Yoshiyama Y; Nishikawa S; Sugiyama T; Kobayashi T; Shimada H; Tomonaga F; Ohdo S; Ogawa N; Nakano S
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2042-3. PubMed ID: 8239630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal variation in nephrotoxicity of low doses of isepamicin in rats.
    Yoshiyama Y; Grenier L; Gourde P; Simard M; Lin L; Morin NJ; Bergeron MG; Labrecque G; Beauchamp D
    Antimicrob Agents Chemother; 1996 Mar; 40(3):802-6. PubMed ID: 8851618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.
    Blunston MA; Yonovitz A; Woodahl EL; Smolensky MH
    Chronobiol Int; 2015; 32(9):1223-32. PubMed ID: 26506922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of ceftriaxone against the nephrotoxicity of isepamicin administered once daily in rats.
    Yoshiyama Y; Yazaki T; Beauchamp D; Kanke M
    Biol Pharm Bull; 1998 May; 21(5):520-3. PubMed ID: 9635511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily dosing of aminoglycosides: how much monitoring is truly required?
    Winston L; Benowitz N
    Am J Med; 2003 Feb; 114(3):239-40. PubMed ID: 12637142
    [No Abstract]   [Full Text] [Related]  

  • 6. Gentamicin nephrotoxicity in the rat: influence of age and diabetes mellitus.
    Ali BH; Bashir AK; Mugamer IT; Tanira MO
    Hum Exp Toxicol; 1996 Jan; 15(1):51-55. PubMed ID: 8845210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of feeding schedule on chronopharmacological aspects of gentamicin in mice.
    Song J; Ohdo S; Ogawa N; Nakano S
    Chronobiol Int; 1993 Oct; 10(5):338-48. PubMed ID: 8261533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily versus multiple-daily dosing of aminoglycosides.
    Craig WA
    J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic nephrotoxicity. A review of pathogenesis and prevention.
    Silverblatt FJ
    Urol Clin North Am; 1975 Oct; 2(3):557-67. PubMed ID: 1103415
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronotoxical study of gentamicin induced nephrotoxicity in rats.
    Yoshiyama Y; Kobayashi T; Tomonaga F; Nakano S
    J Antibiot (Tokyo); 1992 May; 45(5):806-8. PubMed ID: 1624385
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of intramuscularly administered isepamicin in man.
    Lin CC; Radwanski E; Korduba C; Affrime M; Cayen MN
    Chemotherapy; 1997; 43(2):86-93. PubMed ID: 9084916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
    Rodriguez-Barbero A; López-Novoa JM; Arévalo M
    Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and pharmacodynamics of isepamicin.
    Tod M; Padoin C; Petitjean O
    Clin Pharmacokinet; 2000 Mar; 38(3):205-23. PubMed ID: 10749517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of aminoglycoside antibiotics in laboratory animals and its predictive value: effects of gentamicin in the rat.
    Maraschin R; Nava A; Caramel C; Conz A; Premoli A; Dezulian V
    Farmaco Prat; 1982 Mar; 37(3):73-80. PubMed ID: 7067803
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimens.
    Pancorbo S; Compty C; Heissler J
    Biopharm Drug Dispos; 1982; 3(1):83-8. PubMed ID: 7082782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary protein level alters gentamicin-induced nephrotoxicity in rats.
    Zeeni N; Selmaoui B; Beauchamp D; Labrecque G; Thibault L
    Physiol Behav; 2007 Apr; 90(5):760-70. PubMed ID: 17336348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.
    Hoffa DE
    Ther Drug Monit; 1989 Sep; 11(5):574-9. PubMed ID: 2815234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dimethyl sulfoxide on gentamicin-induced nephrotoxicity in rats.
    Ali BH; Mousa HM
    Hum Exp Toxicol; 2001 Apr; 20(4):199-203. PubMed ID: 11393273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats.
    Beauchamp D; Collin P; Grenier L; LeBrun M; Couture M; Thibault L; Labrecque G; Bergeron MG
    Antimicrob Agents Chemother; 1996 Mar; 40(3):670-6. PubMed ID: 8851591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.